Results from a recent retrospective study indicate that multiple myeloma patients who receive stem cell transplants may be at greater risk than the general population of developing atrial fibrillation, the most common type of irregular heartbeat.

The researchers also found that myeloma patients with kidney failure, heart failure, or high blood pressure were at the greatest risk of developing atrial fibrillation after a stem cell transplant.

The researchers suggest that selecting appropriate patients for stem cell transplantation, correcting risk factors, and using preventative treatment may prevent the occurrence of irregular heart beat …